دورية أكاديمية

Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial

التفاصيل البيبلوغرافية
العنوان: Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial
المؤلفون: Rossi L., Biagioni C., McCartney A., Migliaccio I., Curigliano G., Sanna G., Moretti E., Minisini A. M., Cinieri S., Tondini C., Arpino G., Bernardo A., Martignetti A., Risi E., Pestrin M., Boni L., Benelli M., Biganzoli L., Di Leo A., Malorni L.
المساهمون: L. Rossi, C. Biagioni, A. Mccartney, I. Migliaccio, G. Curigliano, G. Sanna, E. Moretti, A.M. Minisini, S. Cinieri, C. Tondini, G. Arpino, A. Bernardo, A. Martignetti, E. Risi, M. Pestrin, L. Boni, M. Benelli, L. Biganzoli, A. Di Leo, L. Malorni
بيانات النشر: BioMed Central Ltd.
سنة النشر: 2019
المجموعة: The University of Milan: Archivio Istituzionale della Ricerca (AIR)
مصطلحات موضوعية: Best sequence, CDK4/6 inhibitor, Metastatic breast cancer, Palbociclib, TREnd trial, Settore MED/06 - Oncologia Medica
الوصف: Currently, there is limited data regarding the effectiveness of standard subsequent line therapies such as endocrine therapy, chemotherapy, or targeted agents after progression on CDK4/6 inhibitor-based regimens. This paper describes time-to-treatment failure beyond progression on palbociclib or palbociclib+endocrine therapy in patients enrolled in the phase II, multicenter TREnd trial. Our results indicate that there is limited benefit from post-palbociclib treatment, regardless of the type of therapy received. A small population of long responders were identified who demonstrated ongoing benefit from a subsequent line of endocrine therapy after progression to palbociclib-based regimens. A translational research program is ongoing on this population of outliers.
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31142370; info:eu-repo/semantics/altIdentifier/wos/WOS:000469474800001; volume:21; issue:1; firstpage:1; lastpage:7; numberofpages:7; journal:BREAST CANCER RESEARCH; http://hdl.handle.net/2434/665555Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85066816663
DOI: 10.1186/s13058-019-1149-5
الإتاحة: https://doi.org/10.1186/s13058-019-1149-5Test
http://hdl.handle.net/2434/665555Test
حقوق: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.70A381D2
قاعدة البيانات: BASE